SANT-1,
304909-07-7,
MFCD01827306,
Shh Signaling Antagonist V,
CHEMBL515916,
(4-Benzyl-piperazin-1-yl)-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-ylmethylene)-amine,
(E)-4-Benzyl-N-((3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene)piperazin-1-amine,
N-[(3,5-Dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene]-4-(phenylmethyl)-1-piperazinamine,
AC1OBMCF,
SCHEMBL1503099,
SCHEMBL10063651,
CHEBI:93466,
DTXSID90425965,
(E)-N-(4-Benzylpiperazin-1-Yl)-1-(3,5-Dimethyl-1-Phenyl-1h-Pyrazol-4-Yl)methanimine,
N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methanimine,
N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenylpyrazol-4-yl)methanimine,
HMS3676P14,
C23H27N5,
EX-A1250,
Tox21_500396,
2700AH,
BDBM50249488,
NSC731871,
s7092,
STL361943,
ZINC12372218,
AKOS001011845,
API0000824,
NSC-731871,
SB19500,
1-Piperazinamine, N-[(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene]-4-(phenylmethyl)-,
NCGC00092291-01,
NCGC00092291-03,
NCGC00186003-01,
NCGC00261081-01,
BC251084,
UPCMLD0ENAT0503-7093:001,
HY-100224,
RT-015632,
CS-0018354,
J-017988,
BRD-K83637872-001-01-7,
4-benzyl-N-((3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene)piperazin-1-amine,
4-benzyl-N-[(E)-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methylidene]piperazin-1-amine,
N-[(3,5-dimethyl-1-phenyl-1H-pyrazol-4-yl)methylene]-4- (phenylmethyl)-1-piperazinamine,
FOORCIAZMIWALX-JJIBRWJFSA-N,
CID6878030,
A8659,
A13095,
(E)-N-(4-BENZYLPIPERAZIN-1-YL)-1-(3,5-DIMETHYL-1-PHENYLPYRAZOL-4-YL)METHANIMINE,
N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenyl-pyrazol-4-yl)methanimine,